Article info
PDFOriginal research
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study
- Correspondence to David Young, Department of Gastroenterology, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK; david.young{at}uhs.nhs.uk
Citation
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study
Publication history
- Received May 4, 2022
- Accepted June 28, 2022
- First published July 19, 2022.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.